Replies to post #97654 on EP Global Communications Inc fka EPGL

[Stentor1]

Lol, the apologists will say that the MPDD was doing great, but they just HAD TO abandon it because well, thats what you do when a product is showing promise.

They couldn't sell it off, they couldn't license it to another company, they just had to completely abandon it??? The reality is they lied about the MPDD's progress to keep the share price up. The MPDD was a failure.

I don't care about failures. It's part of the progression of a company that is trying to grow. What I do care about is that they lied to shareholders.

[Atlanta1]

Exactly what was the dollar amount of MPDD sales that were reported per these claims???? It sure seems like the situation was grossly misrepresented by Hayes:


EPGL Med @EPGLMed · 6 May (2013)

< EPGL Alert - EPGL is seeing demand continue to build for MPDD in US, Europe and Asia pipelines. Strong sales expected going into Q3 Q4. >

< EPGL Alert: EPGL team continues filing new patents resulting from TopSpin BioMEMS technology platform. First prototype devices in progress. >

< EPGL As MPDD production and delivery to Asia, US and Europe ramps up here in Q2, US doctors will begin receiving MPDD's this month. >

< EPGL Q2 expected to be impressive with steady MPDD sales growth moving into Q3 and Q4. Strong demand building for MPDD in all market. >